Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

InflaRx Undaunted By Dermatology Rivals

Jun 06 2024

• By Elizabeth Cairns

Lightspring/Shutterstock.com

Related Content

The Runners And Riders In Hidradenitis Suppurativa

Oct 05 2023

Remibrutinib REMIXes The Itch Record

Feb 28 2024

Incyte Aims At Mild Hidradenitis Suppurativa

Mar 11 2024

Related Companies

InflaRx N.V.

Roche Holding AG

Novartis AG

Celldex Therapeutics, Inc.

UCB S.A.

Incyte Corporation

Amgen, Inc.

Additional Topics

Clinical Trials Commercial Companies Research & Development Inflammation Dermatology Immune Disorders BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window